OR WAIT null SECS
The Latvian government and Pharma have signed a letter of intent on June 29, 2015, agreeing on measures and a mutual cooperation in projects that will help improve medicines access and health outcomes in Latvia.
The Latvian Ministry of Health, the Latvian Academy of Sciences, the European Association of Pharmaceutical Industries and Associations (EFPIA), and the Association of International Research-based Pharmaceutical Manufacturers (SIFFA) have signed a letter of intent on June 29, 2015, agreeing on measures and a mutual cooperation in projects that will help improve medicines access and health outcomes in Latvia.
The government is hoping to promote stable business conditions while improving access to innovative medicines and investments in research. The Ministry of Health and the pharmaceutical industry have agreed on the provision of transparency in the reimbursed medicines system, availability of medicines, result-oriented uptake of medicines, and the industry’s support to ensure the availability of medicines. A working group will be established to develop specific proposals for a step wise collaboration.
The letter of intent underscores the continued efforts of the research-based pharmaceutical industry to forge partnership with governments across Europe to support the sustainability of national health services and increase access to innovative medicines for the benefit of patients.